These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 286493)

  • 21. [Specific immunity regulation in acute leukemia and its therapeutic potentials].
    Bergol'ts VM; Kisliak NS; Eremeev VS; Rumiantsev AG; Akimova GV
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):21-5. PubMed ID: 6946411
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.
    Pion S; Fontaine P; Baron C; Gyger M; Perreault C
    J Clin Invest; 1995 Apr; 95(4):1561-8. PubMed ID: 7706462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune stimulation as oncologic therapy, especially in acute leukemia].
    Olsson L
    Ugeskr Laeger; 1977 Apr; 139(15):876-9. PubMed ID: 265645
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of antibodies to soluble blast cell antigens in acute leukemia].
    Golodnenkova VN; Bulycheva TI; Danilevich SV
    Vopr Onkol; 1980; 26(9):17-22. PubMed ID: 6932783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antileukemic cellular immunity characteristics in the immunotherapy of acute lympholeukemia in children].
    Bergol'ts VM; Osipov SG; Eremeev VS; Rumiantseva AG; Akimova GV
    Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):12-4. PubMed ID: 6948291
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monoclonal antibodies (NU-N1 and NU-N2) reactive with common acute lymphoblastic leukemia antigen].
    Matsuo Y; Hagiwara S; Okubo K; Matsumoto K; Sagawa K; Yokoyama MM
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):775-83. PubMed ID: 3862322
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.
    Carrel S; De Tribolet N; Gross N
    Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
    Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
    Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
    [No Abstract]   [Full Text] [Related]  

  • 31. [10 years of immunotherapy of leukemia and cancers].
    Mathe G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; Cattan A; Schneider M
    Ann Med Interne (Paris); 1975 Feb; 126(2):107-14. PubMed ID: 1065250
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].
    Ruiz-Cabello F; González M; López MA; Cabrera A; San Miguel J; Garrido F
    Sangre (Barc); 1985; 30(2):190-6. PubMed ID: 3859940
    [No Abstract]   [Full Text] [Related]  

  • 34. [The immunity mechanisms, for or against the cancer patient?].
    Mathé G
    Nouv Presse Med; 1973 Mar; 2(9):553-5. PubMed ID: 4574115
    [No Abstract]   [Full Text] [Related]  

  • 35. Difference between monoclonal antibodies against the common acute leukemia antigen from two different hybridomas.
    Canon C; Eichler-Reiss F; Reizenstein P; Mathé G
    Anticancer Res; 1983; 3(6):407-8. PubMed ID: 6230985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute lymphoblastic leukemia with an abnormal T8 phenotype].
    Blanco A; Guisasola JA; Valbuena C; Solís P; Villar A; Sánchez Villares E
    Sangre (Barc); 1984; 29(3):302-9. PubMed ID: 6237441
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy of leukemia and lymphoma.
    Murphy S; Hersh E
    Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].
    Ortega JJ; Javier G
    Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428
    [No Abstract]   [Full Text] [Related]  

  • 40. [A transient appearance of CALLA positive blastoid cells after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia].
    Komatsu N; Takagi S; Amemiya Y; Sakamoto S; Miura Y
    Rinsho Ketsueki; 1987 Feb; 28(2):250-3. PubMed ID: 2952819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.